Advances and challenges in the multidisciplinary diagnosis and treatment of pancreatic cancer
10.3969/j.issn.1001-5256.2019.05.001
- VernacularTitle:胰腺癌多学科诊疗进展与挑战
- Author:
Taiping ZHANG
1
;
Jiangdong QIU
;
Mengyu FENG
Author Information
1. Department of Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
- Publication Type:Research Article
- Keywords:
pancreatic neoplasms;
diagnosis;
therapeutics;
editorial
- From:
Journal of Clinical Hepatology
2019;35(5):937-940
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer is a highly malignant tumor in the digestive system and has a low rate of surgical resection and poor prognosis. Since pancreatic cancer has unique biological behaviors, surgical resection alone cannot meet the need of clinical treatment. With the popularization of the concept of multimodality therapy, multidisciplinary collaboration can integrate the superior resources of disciplines and develop standardized and individualized diagnosis and treatment process based on patients′ conditions. It can help clinicians to observe the indications for neoadjuvant therapy in patients with pancreatic cancer and develop individualized surgical and adjuvant treatment regimens and has achieved a good effect in the treatment of pancreatic cancer. This article summarizes the advances and challenges in the multidisciplinary diagnosis and treatment of pancreatic cancer, in order to improve the level of multidisciplinary diagnosis and treatment of pancreatic cancer in China and the prognosis of patients with pancreatic cancer.
